Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natural Killer T-Cells | 6 | 2023 | 82 | 1.370 |
Why?
|
Neuroblastoma | 5 | 2023 | 520 | 0.890 |
Why?
|
Salmonella typhimurium | 2 | 2014 | 43 | 0.810 |
Why?
|
Salmonella enterica | 2 | 2012 | 9 | 0.720 |
Why?
|
Antigens | 2 | 2012 | 155 | 0.720 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2023 | 263 | 0.690 |
Why?
|
Gangliosides | 1 | 2019 | 69 | 0.620 |
Why?
|
Interleukin-15 | 1 | 2019 | 92 | 0.620 |
Why?
|
Vaccines, Attenuated | 2 | 2014 | 174 | 0.540 |
Why?
|
Immunotherapy, Adoptive | 4 | 2023 | 826 | 0.490 |
Why?
|
Cancer Vaccines | 1 | 2014 | 175 | 0.410 |
Why?
|
Vaccines, Synthetic | 2 | 2012 | 317 | 0.400 |
Why?
|
Antigens, Neoplasm | 1 | 2014 | 386 | 0.380 |
Why?
|
Drug Carriers | 1 | 2012 | 100 | 0.370 |
Why?
|
Bacterial Proteins | 3 | 2014 | 889 | 0.360 |
Why?
|
Drug Delivery Systems | 1 | 2012 | 186 | 0.350 |
Why?
|
Virulence Factors | 1 | 2012 | 176 | 0.350 |
Why?
|
Vaccination | 2 | 2012 | 953 | 0.320 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2009 | 158 | 0.300 |
Why?
|
Dendritic Cells | 1 | 2010 | 409 | 0.280 |
Why?
|
Recombinant Proteins | 1 | 2010 | 1390 | 0.270 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 1327 | 0.270 |
Why?
|
Macrophages | 1 | 2010 | 619 | 0.260 |
Why?
|
Mice, SCID | 4 | 2023 | 568 | 0.250 |
Why?
|
Lymphocyte Activation | 4 | 2023 | 691 | 0.250 |
Why?
|
Mice, Inbred NOD | 3 | 2023 | 285 | 0.240 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2023 | 14 | 0.210 |
Why?
|
Mice | 9 | 2023 | 17630 | 0.210 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 2521 | 0.190 |
Why?
|
Ovalbumin | 2 | 2012 | 318 | 0.180 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2023 | 681 | 0.170 |
Why?
|
Neoplasms | 1 | 2014 | 2771 | 0.170 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2020 | 482 | 0.160 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2019 | 882 | 0.160 |
Why?
|
Animals | 9 | 2023 | 34072 | 0.150 |
Why?
|
Mice, Inbred BALB C | 2 | 2012 | 1003 | 0.150 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 1062 | 0.140 |
Why?
|
Antigen-Presenting Cells | 2 | 2016 | 118 | 0.140 |
Why?
|
L-Selectin | 1 | 2016 | 21 | 0.130 |
Why?
|
Bone Neoplasms | 1 | 2020 | 419 | 0.130 |
Why?
|
Cell Proliferation | 2 | 2019 | 2285 | 0.120 |
Why?
|
Membrane Proteins | 2 | 2014 | 1533 | 0.120 |
Why?
|
Ubiquitin-Specific Proteases | 1 | 2014 | 20 | 0.110 |
Why?
|
Mice, Inbred C57BL | 3 | 2014 | 4406 | 0.110 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2014 | 58 | 0.110 |
Why?
|
DEAD-box RNA Helicases | 1 | 2014 | 121 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 2 | 2016 | 767 | 0.100 |
Why?
|
Apoptosis | 1 | 2019 | 1789 | 0.100 |
Why?
|
T-Lymphocytes | 2 | 2012 | 1706 | 0.100 |
Why?
|
Salmonella Vaccines | 1 | 2012 | 7 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2014 | 394 | 0.100 |
Why?
|
Hemolysin Proteins | 1 | 2012 | 32 | 0.100 |
Why?
|
Heat-Shock Proteins | 1 | 2012 | 195 | 0.090 |
Why?
|
Bacterial Toxins | 1 | 2012 | 175 | 0.090 |
Why?
|
Regulon | 1 | 2010 | 11 | 0.090 |
Why?
|
Protein Transport | 1 | 2012 | 369 | 0.090 |
Why?
|
RNA, Bacterial | 1 | 2010 | 54 | 0.090 |
Why?
|
Plasmids | 1 | 2010 | 510 | 0.080 |
Why?
|
Cells, Cultured | 2 | 2016 | 3038 | 0.080 |
Why?
|
Virulence | 1 | 2009 | 262 | 0.080 |
Why?
|
Bone Marrow Cells | 1 | 2010 | 259 | 0.080 |
Why?
|
Multigene Family | 1 | 2009 | 298 | 0.080 |
Why?
|
DNA, Bacterial | 1 | 2009 | 478 | 0.070 |
Why?
|
Base Sequence | 1 | 2009 | 3090 | 0.060 |
Why?
|
Transcription Factors | 2 | 2014 | 2582 | 0.060 |
Why?
|
Molecular Sequence Data | 1 | 2009 | 3878 | 0.060 |
Why?
|
Humans | 7 | 2023 | 124593 | 0.060 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2023 | 12 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2023 | 31 | 0.050 |
Why?
|
Etanercept | 1 | 2023 | 41 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 1702 | 0.050 |
Why?
|
beta Catenin | 1 | 2023 | 202 | 0.050 |
Why?
|
Monocytes | 1 | 2023 | 351 | 0.040 |
Why?
|
Vidarabine | 1 | 2020 | 80 | 0.040 |
Why?
|
Carcinogenesis | 1 | 2023 | 331 | 0.040 |
Why?
|
Immunity | 1 | 2020 | 191 | 0.040 |
Why?
|
Cyclophosphamide | 1 | 2020 | 418 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2016 | 3729 | 0.030 |
Why?
|
Receptors, Antigen | 1 | 2016 | 34 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 717 | 0.030 |
Why?
|
Lymphoma, B-Cell | 1 | 2016 | 141 | 0.030 |
Why?
|
Rhabdoviridae Infections | 1 | 2014 | 1 | 0.030 |
Why?
|
DEAD Box Protein 58 | 1 | 2014 | 12 | 0.030 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2014 | 17 | 0.030 |
Why?
|
Vesiculovirus | 1 | 2014 | 13 | 0.030 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2014 | 43 | 0.030 |
Why?
|
Cell Survival | 1 | 2016 | 806 | 0.030 |
Why?
|
Child | 2 | 2023 | 24374 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2014 | 375 | 0.020 |
Why?
|
Cytokines | 1 | 2016 | 1290 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 3337 | 0.020 |
Why?
|
Female | 2 | 2014 | 66482 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 2043 | 0.020 |
Why?
|
Male | 2 | 2020 | 61191 | 0.010 |
Why?
|